%D8%AA%D9%8A%D8%B1%D9%8A%D8%A8%D8%A7%D8%B1%D8%A7%D8%AA%D9%8A%D8%AF%D8%AA%D8%B1%D9%8A%D9%BE%D8%A7%D8%B1%D8%A7%D8%AA%D9%8A%D8%AATeriparatidTeriparatidTeriparatideTeriparatida%D8%AA%D8%B1%DB%8C%E2%80%8C%D9%BE%D8%A7%D8%B1%D8%A7%D8%AA%D8%A7%DB%8C%D8%AFTeriparatideTeriparatide%E3%83%86%E3%83%AA%E3%83%91%E3%83%A9%E3%83%81%E3%83%89TeryparatydTeriparatidaTeriparatidTeriparatidQ411781%E7%89%B9%E7%AB%8B%E5%B8%95%E8%82%BD
about
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and DenosumabDose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With OsteoporosisThe Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral DensityA Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With ForteoSecond Study of the Effect of Teriparatide on Hip Fracture HealingEffect of Teriparatide on Hip Fracture HealingComparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisPreoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion SurgeryG56W1 in Women With Postmenopausal OsteoporosisComparation of Treatment Strategies for OVF: Teriparatide Injection and PVPEffect of PTH(1-34) Treatment on Fracture Healing in VivoTeriparatide as a Chondroregenerative Therapy in OAForteo Trial on Idiopathic Osteoporosis in Premenopausal WomenTeriparatide Treatment in Patients With Inherited OsteoporosisPharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal WomenTeriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of ActionUse of Forteo (Teriparatide) in Posterolateral Lumbar Spine FusionStudy of Teriparatide (FORTEO) to Treat Adults With Osteogenesis ImperfectaTreatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic AcidExamination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab TherapyTeriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA TrialEarly Effects of Parathyroid Hormone (PTH) on the Proximal FemurEffect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord InjurySafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal WomenA Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal WomenµMRI of Therapeutic Intervention in Postmenopausal OsteoporosisThe Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones FracturesTeriparatide for Postsurgical HypoparathyroidismEnhancing Osteoporosis Therapy: Can We Open the Anabolic Window?Does Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With OsteoporosisCombination Risedronate - Parathyroid Hormone Trial in Male OsteoporosisStem Cell Recruitment in Osteoporosis TherapyStudy to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone MassForteo for the Treatment of Unexplained Osteoporosis in Premenopausal WomenA Study for Teriparatide in Severe OsteoporosisEffects of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCyclic Versus Daily Teriparatide on Bone MassWeekly vs Daily Teriparatide Therapy in Severe Postmenopausal OsteoporosisAcute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
P4844
Successful treatment of pathologic femoral shaft fracture associated with large arteriovenous malformations using a 3-dimensional external fixator and teriparatide: a case reportMolecular understanding of pharmacological treatment of osteoporosisCan Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVECost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
P921
Q61894360-53E48FA0-73DC-42DC-809D-29558C655F7DQ61918101-813A091C-7A8F-494E-BF28-0A7DC5FC897BQ61924412-8342FC46-F1A5-4471-8752-B1DD67028A88Q61934237-C6937802-267E-4635-BB53-5CBC5C6DFC75Q61955334-74C11F0F-1D2C-41A7-82BA-3B38CEFF31E8Q61955335-C34721E6-43FA-4DE0-BE0B-5FCC5FB6BC96Q61980172-EFBD9ADE-A7C7-4B6E-8493-CF4745989952Q62031401-58B513A0-8710-4B66-BF08-4FBA2F1A4D6EQ62039821-2E221AAB-CE32-41F9-A8F6-D53A64585F08Q62054025-EBBF5806-7005-4D16-B04B-5400F60DFA6BQ63062720-8FF8CE63-7D3A-4FD1-A11B-B2852764B248Q63228967-F65EA5CD-575F-4150-804D-05424B0FC20EQ63322434-9720DDF3-D9D2-43FC-B12B-1FED5A6A4DA8Q63335455-337B5CA2-6E12-402E-845F-275EEDA09A87Q63336114-EB644313-2255-4CBB-8B4D-A7F93E315F6EQ63339487-F613869A-DF34-4A1C-A4E8-2DF2FAA95FE1Q63339576-53B11661-D897-410B-B38B-DCEA74E378ECQ63574105-B1F89DB3-A745-4348-A8C4-297C8B1C06D4Q63596139-F3428542-D7EE-48BF-82B3-E1088641EA0CQ63596738-EA31A238-7FAD-42FA-AEA8-19B069F58D6DQ63807354-D55A9ABB-98F4-4D01-BEF3-CD5A2F6FF08DQ63813609-A0CBE299-015E-4B06-8EFB-42F133FEACF6Q63817103-22713205-3034-48AE-8304-43A38F981578Q63817168-E7BC2450-384A-4082-946B-D5CD9D4F1F88Q63819064-25331050-9839-405E-9D6F-03E7878AACEFQ63829086-B15296CD-D3E9-4D4A-A9A6-076C84ABEFA0Q63830865-E0DEC8C6-30D8-4312-86C4-9FC3D47F2EA0Q63831248-412DAD47-AD62-4AAD-96A1-5880677027DDQ63832740-5B6E2578-8063-46B8-A462-1913CDC7A7E5Q63834415-70A7990D-AF15-4335-BE73-4EBA9B4E383CQ63839357-28EABFAE-30EC-43D3-99D4-994191343D5FQ63840989-C9EF79B5-A042-4CA4-880C-8E698507E136Q63841160-4583C0E9-8129-4C3F-BF50-4F13FADC0273Q63843522-B88A3FC4-7BDD-4543-A1BA-4C50D6653A0EQ64043496-4C465C06-0D5F-45F9-AA23-C1ED9C02A07BQ64043669-5DD51703-F4F1-4539-AF05-206746B73E5CQ64047817-17CB799D-B642-4D61-A009-BCEC01D5966EQ64048113-172157F2-BD31-46AB-B6F2-5F79F412932FQ64070501-372643A6-7925-4241-82BF-E3CE600011D5Q64071266-D758C7BB-1FC5-49E7-B0F1-2A101ABD39A3
P4844
description
Protein
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Teriparatid
@de
Teriparatid
@sh
Teriparatid
@sr
Teriparatida
@es
Teriparatida
@pt
Teriparatide
@en
Teriparatide
@nl
Teryparatyd
@pl
teriparatid
@cy
teriparatid
@nn
type
label
Teriparatid
@de
Teriparatid
@sh
Teriparatid
@sr
Teriparatida
@es
Teriparatida
@pt
Teriparatide
@en
Teriparatide
@nl
Teryparatyd
@pl
teriparatid
@cy
teriparatid
@nn
altLabel
Forsteo
@de
Forteo
@cy
Forteo
@en
PTH134
@en
prefLabel
Teriparatid
@de
Teriparatid
@sh
Teriparatid
@sr
Teriparatida
@es
Teriparatida
@pt
Teriparatide
@en
Teriparatide
@nl
Teryparatyd
@pl
teriparatid
@cy
teriparatid
@nn
P2175
P31
P486
P592
P6366
P646
P661
P662
P665
P683
P117
P1748
P2067
4,116.134297